Regulation
Pioneer Institute study finds IRA discourages non-opioid drug innovation
The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.
Acorda loses Nasdaq listing to cap biotech’s end
FDA grants orphan drug status to NovelMed’s PNH treatment
Norgine seeks approval for high-risk neuroblastoma treatment
Glenmark announces recall of high blood pressure medication in US
SAHPRA recalls two Kenvue cough syrup batches
